FDA Investigator J Paul Kirwan, PhD
J Paul Kirwan, PhD has inspections in 1 countries as of 25 Oct 2021. J Paul Kirwan, PhD has collaborated with a combined 632 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
25 Oct 2021
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Bo Chi, PhD,
Candace Y Gomez Broughton,
Charisse K Green,
Dr. Robert C Horan, MD,
Guerlain Ulysse,
Jacqueline Mdiaz Albertini,
Jay T Wong,
Jens Fricke,
Kalavati Suvarna, PhD,
Lakshmi Narasimhan, PhD,
Laura Fontan, MS,
LCDR Chad N Thompson,
Margaret E Sarles,
Maria Joselopez Barragan, PhD,
Maxwell Van Tassell, PhD,
Michelle Y Clark Stuart,
Milos Dokmanovic, PhD,
Mindy M Chou,
Omotunde O Osunsanmi,
Patrick C Klotzbuecher,
Paul Mouris,
Rajiv R Srivastava,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert J Martin,
Sarah Kennett, PhD,
Sony Mathews,
Thuy T Nguyen, LCDR,
Tzanko Stantchev,
Wayne E Seifert,
Willie Wilson
J Paul Kirwan, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2015 | FDA 483 | Regeneron Pharmaceuticals, Inc. - Form 483, 2015-04-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more